GSK plc has released its block listing six-monthly review for the period from May 1, 2024, to October 31, 2024, covering three employee share schemes. The GlaxoSmithKline plc 2017 Deferred Annual Bonus Plan maintains 115,518 unallotted securities, with no changes during the period.Under the Share Save Plan 2012, 155,786 securities were issued/allotted, reducing the balance from 673,024 to 517,238 shares. The Share Save Plan 2022 saw a minor allocation of 19,867 securities, leaving a balance of 975,390 shares. No increases were applied to any of the schemes during this period.The total unallotted securities across all three schemes stand at approximately 1.6 million shares, demonstrating GSK's ongoing commitment to employee share ownership programs.

GSK plc has released its block listing six-monthly review for the period from May 1, 2024, to October 31, 2024, covering three employee share schemes. The GlaxoSmithKline plc 2017 Deferred Annual Bonus Plan maintains 115,518 unallotted securities, with no changes during the period.Under the Share Save Plan 2012, 155,786 securities were issued/allotted, reducing the balance from 673,024 to 517,238 shares. The Share Save Plan 2022 saw a minor allocation of 19,867 securities, leaving a balance of 975,390 shares. No increases were applied to any of the schemes during this period.The total unallotted securities across all three schemes stand at approximately 1.6 million shares, demonstrating GSK's ongoing commitment to employee share ownership programs.